BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33507704)

  • 1. Profiling of Bile Microbiome Identifies District Microbial Population between Choledocholithiasis and Cholangiocarcinoma Patients.
    Dangtakot R; Intuyod K; Ahooja A; Wongwiwatchai J; Hanpanich P; Lulitanond A; Chamgramol Y; Pinlaor S; Pinlaor P
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):233-240. PubMed ID: 33507704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Preliminary Study of Biliary Microbiota in Patients with Bile Duct Stones or Distal Cholangiocarcinoma.
    Chen B; Fu SW; Lu L; Zhao H
    Biomed Res Int; 2019; 2019():1092563. PubMed ID: 31662965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.
    Chng KR; Chan SH; Ng AHQ; Li C; Jusakul A; Bertrand D; Wilm A; Choo SP; Tan DMY; Lim KH; Soetinko R; Ong CK; Duda DG; Dima S; Popescu I; Wongkham C; Feng Z; Yeoh KG; Teh BT; Yongvanit P; Wongkham S; Bhudhisawasdi V; Khuntikeo N; Tan P; Pairojkul C; Ngeow J; Nagarajan N
    EBioMedicine; 2016 Jun; 8():195-202. PubMed ID: 27428430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.
    Saab M; Mestivier D; Sohrabi M; Rodriguez C; Khonsari MR; Faraji A; Sobhani I
    PLoS One; 2021; 16(3):e0247798. PubMed ID: 33690612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
    Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
    Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of biliary and duodenal microbiota in patients with primary and recurrent choledocholithiasis.
    Liu F; Wang ZK; Li MY; Zhang XL; Cai FC; Wang XD; Gao XF; Li W
    Health Inf Sci Syst; 2024 Dec; 12(1):29. PubMed ID: 38584761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
    Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with Helicobacter bilis but not Helicobacter hepaticus was Associated with Extrahepatic Cholangiocarcinoma.
    Segura-López FK; Avilés-Jiménez F; Güitrón-Cantú A; Valdéz-Salazar HA; León-Carballo S; Guerrero-Pérez L; Fox JG; Torres J
    Helicobacter; 2015 Jun; 20(3):223-30. PubMed ID: 25582431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
    Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
    Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis.
    Nishimura M; Naka S; Hanazawa K; Tani T; Fukami M; Okada S; Fujiyama Y
    Dig Dis Sci; 2005 Nov; 50(11):2153-8. PubMed ID: 16240231
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand.
    Chamadol N; Khuntikeo N; Thinkhamrop B; Thinkhamrop K; Suwannatrai AT; Kelly M; Promthet S
    BMJ Open; 2019 Mar; 9(3):e023217. PubMed ID: 30898798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Care Intervention to Prevent and Control Cholangiocarcinoma: Lesson from Nakhon Ratchasima, Thailand.
    Kaewpitoon SJ; Loyd RA; Rujirakul R; Wakkuwattapong P; Tongtawee T; Matrakool L; Panpimanmas S; Kompor P; Norkaew J; Kujapun J; Chavengkun W; Ponphimai S; Pothipim M; Phatisena T; Eksanti T; Polsripradist P; Padchasuwan N; Benjaoran F; Namvichaisirikul N; Kuebkuntod P; Kaewpitoon N
    J Med Assoc Thai; 2016 Oct; 99 Suppl 7():S144-50. PubMed ID: 29901974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
    Qiu G; Ma D; Li F; Sun D; Zeng Z
    Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.
    Thanan R; Kaewlert W; Sakonsinsiri C; Chaiprasert T; Armartmuntree N; Muengsaen D; Techasen A; Klanrit P; Lert-Itthiporn W; Pinlaor S; Pairojkul C
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32151057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter Species are Possible Risk Factors of Cholangiocarcinoma.
    Kaewpitoon SJ; Loyd RA; Rujirakul R; Panpimanmas S; Matrakool L; Tongtawee T; Kootanavanichpong N; Pengsaa P; Kompor P; Chavengkun W; Kujapun J; Norkaew J; Ponphimai S; Padchasuwan N; Polsripradist P; Eksanti T; Phatisena T; Kaewpitoon N
    Asian Pac J Cancer Prev; 2016; 17(1):37-44. PubMed ID: 26838240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.
    Chen MH; Yen CC; Cheng CT; Wu RC; Huang SC; Yu CS; Chung YH; Liu CY; Chang PM; Chao Y; Chen MH; Chen YF; Chiang KC; Yeh TS; Chen TC; Huang CY; Yeh CN
    Oncotarget; 2015 Sep; 6(27):23594-608. PubMed ID: 26090720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
    Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytological diagnosis of biliary cryptococcosis in an immunocompromised patient with mid common bile duct stricture masquerading as cholangiocarcinoma.
    Burad DK; Ramakrishna B
    Cytopathology; 2017 Apr; 28(2):164-167. PubMed ID: 27592857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.